NMRA
USDNeumora Therapeutics Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$2.560
고가
$2.920
저가
$2.550
거래량
1.60M
기업 기본 정보
시가총액
480.9M
산업
생명공학
국가
United States
거래 통계
평균 거래량
1.36M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
Neumora Therapeutics to Participate in Upcoming Conferences in November
WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NASDAQ:NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel
Needham Maintains Buy on Neumora Therapeutics, Raises Price Target to $8
Needham analyst Ami Fadia maintains Neumora Therapeutics with a Buy and raises the price target from $6 to $8.
Guggenheim Upgrades Neumora Therapeutics to Buy, Announces $14 Price Target
Guggenheim analyst Yatin Suneja upgrades Neumora Therapeutics from Neutral to Buy and announces $14 price target.
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction NMRA-215 demonstrated best-in-class weight loss of up to 26% in combination with semaglutide Class-leading
